U.S. Aerospace & Defense Stock News

Urban Outfitters (URBN) is in focus as investors look ahead to its upcoming quarterly earnings report, with forecasts pointing to year over year growth in both earnings per share and revenue. See our latest analysis for Urban Outfitters. Urban Outfitters’ recent share price moves reflect this mix of earnings expectations and business updates. The stock has a 1-day share price return of 2.19%, while the 1-year total shareholder return declined 3.56%. This sits alongside a very large 3-year...

Recent share performance and business snapshot Integra LifeSciences Holdings (IART) has drawn fresh attention after a mixed stretch for the stock, with a gain over the past 3 months but a decline over the past month and past week. The company has a market value of about US$1.29b and last closed at US$16.74 on 19 August 2026. Reported annual revenue is US$1.65b, with a net loss of US$7.24m, and a neutral value score of 5. Integra LifeSciences Holdings generates most of its revenue from...

Earlier in August 2026, Levi’s Vintage Clothing released a painstakingly recreated limited-edition run of 800 pairs of rare 1942 501 jeans, which quickly sold out as collectors and denim enthusiasts snapped up the historically accurate pieces. This surge in demand for a heritage-inspired capsule highlights how Levi Strauss can deepen brand loyalty and pricing power by tapping into its archival storytelling and scarcity-driven product drops. Next, we’ll examine how the strong sell-out of this...

Earlier this week, F5 introduced major enhancements to its F5 AI Gateway and integrated it into the F5 AI Security Platform, adding centralized policy enforcement, cost optimization tools, and expanded deployment options across SaaS and hybrid multicloud environments. A key angle is that F5 is positioning its AI Gateway as a unified control plane for both AI security and spending, giving enterprises granular governance over model access, agent tools, data protection, and token usage in one...

We wouldn't blame Corcept Therapeutics Incorporated ( NASDAQ:CORT ) shareholders if they were a little worried about...

In August 2026, DoorDash, Inc. and Gap announced a nationwide partnership enabling rapid delivery of Gap and Gap Factory apparel from participating stores, supported by limited-time back-to-school discounts for qualifying orders fulfilled via DoorDash. This collaboration extends Gap’s reach into on-demand retail, giving the brands access to DoorDash’s fast-growing marketplace and large U.S. customer base at a key seasonal spending period. Next, we’ll examine how adding on-demand DoorDash...

With fresh readings on consumer confidence and inflation about to hit, Wall Street is reassessing how resilient household spending really is and what that could mean for small consumer stocks. That creates an opening for investors who want to position ahead of any swing in sentiment rather than react after the fact. This article walks through three U.S. small cap consumer discretionary retailers exposed to this news, and why they deserve a closer look now. The three stocks below are just a...

ServisFirst Bancshares stock reaction and recent return profile ServisFirst Bancshares (SFBS) has drawn investor attention after recent trading, with the stock last closing at $43.34. Short term performance has been mixed, with the share price down over the past week but roughly flat over the past month. See our latest analysis for ServisFirst Bancshares. Over a longer horizon, ServisFirst Bancshares has delivered a 67.59% three year total shareholder return and a 27.25% five year total...

In recent weeks, Bio-Rad Laboratories reported continued growth in its digital PCR business, supported by strong instrument sales and contributions from the Stilla Technologies portfolio, while its Life Science segment faced softer demand and the company maintained a cautious full-year 2026 revenue and margin outlook. At the same time, management has launched a restructuring program aimed at delivering cost savings and lifting operating margins by 2027, highlighting a shift toward efficiency...

Recent securities class action filings against PROCEPT BioRobotics (PRCT) accuse the company of misleading investors on handpiece sales, undisclosed discount programs, and inflated revenue. The allegations are raising fresh questions around its reported growth, guidance cuts, and stock volatility. See our latest analysis for PROCEPT BioRobotics. The recent wave of lawsuits helps explain why PROCEPT BioRobotics has had a weak year to date, with the stock showing a 30 day share price return of...

In August 2026, Invesco Ltd. introduced Invesco Solutions & Custom Strategies, a unified global platform that combines its public and private market capabilities across active and passive strategies, alongside custom models and separately managed accounts, while also cutting management fees and offering discounted redemptions plus up to US$150 million of added capital to ease a backlog in its US$12.70 billion Invesco Core Real Estate, USA fund. This combination of a more integrated,...

Uber Technologies stock has delivered a strong 93.7% return over the past 5 years, yet its current valuation checks and recent share price performance raise questions about how much upside is still on the table. With mixed signals from recent news, including regulatory scrutiny and expansion into autonomous and drone services, investors are weighing how much of Uber’s long term story is already reflected in the price. Over 5 years, Uber Technologies has returned 93.7%, which puts the current...

In August 2026, Zenas BioPharma, Inc. reported second-quarter and first-half 2026 results showing US$1,000,000 in quarterly revenue and a sharply higher net loss of US$111,460,000, while also announcing the upcoming transition of Chief Financial Officer Jennifer Fox to a Strategic Advisor role and interim financial leadership by President and COO Joe Farmer. At the same time, Zenas added industry veteran Christy Oliger to its board, bringing extensive commercial experience from leading large...

Macy's (M) is back in focus after its stock closed at $22.58, a 3.5% decline from the prior session, ahead of the retailer's September 10, 2026 earnings release. See our latest analysis for Macy's. The recent 1 day share price return of 1.06% to $22.82 comes after a weaker 30 day share price return of 6.21% and a much stronger 1 year total shareholder return of 74.41%. This suggests long term momentum while short term sentiment has cooled ahead of Macy's upcoming earnings. If Macy's recent...

Sociedad Química y Minera de Chile S.A. ( NYSE:SQM ) just released its second-quarter report and things are looking...

Some Nu Holdings Ltd. ( NYSE:NU ) shareholders may be a little concerned to see that the Chief Risk Officer, Henrique...

Last week, Bicycle Therapeutics plc's (NASDAQ:BCYC) stock jumped 12%, but insiders who sold US$523k worth of stock in...

Anyone interested in Burke & Herbert Financial Services Corp. ( NASDAQ:BHRB ) should probably be aware that the...

Rezolute, Inc. ( NASDAQ:RZLT ) is possibly approaching a major achievement in its business, so we would like to shine...

Medpace Holdings (MEDP) has drawn fresh attention after recent share price moves, with the stock closing at $620.75 on 19 August 2026. Investors are assessing how this valuation lines up with the company’s fundamentals. See our latest analysis for Medpace Holdings. For context, Medpace Holdings has logged a 17.54% 1 month share price return and a 43.43% 3 month share price return, while the 1 year total shareholder return is 33.89% and the 5 year total shareholder return is 243.64%. This...

Blackstone (BX) is back in focus after NVIDIA announced new partnerships on August 10, 2026, to create compute financing platforms intended to mobilize over $500b of third party capital for AI infrastructure. See our latest analysis for Blackstone. For context, Blackstone's 30 day share price return of 16.7% and 90 day gain of 21.0% point to building momentum, even though the year to date share price is still down 9.7% and the 1 year total shareholder return is down 12.5%. At the same time,...

MetLife preferred dividend declaration and what it means for investors MetLife (MET) declared a fresh set of preferred stock dividends for the third quarter of 2026, a routine capital allocation move that gives investors more detail on the company’s funding and payout structure. The board approved payments on several non cumulative preferred series, with different coupon structures and liquidation preferences that appeal to distinct investor income needs. These dividends are scheduled to be...

With central banks signaling a cautious stance as inflation risks linger, investors are again paying close attention to who is actually steering the companies they own. Founder led businesses often keep a sharper eye on capital allocation and long term reputation. That can matter when money feels more expensive. This article highlights three founder led stocks from our screener that show how aligned leadership can shape potential resilience. The stocks below are just a starter set, and the...

Philip Morris International (PM) is back in focus after the U.S. FDA granted Marketing Granted Orders for 11 ZYN ULTRA moist oral nicotine pouch products, expanding the company’s regulated smoke free portfolio. See our latest analysis for Philip Morris International. The FDA approval arrives after a run of steady news from Philip Morris International, including Q2 2026 results that met market expectations and a recent ZYN-branded art initiative in the U.S. While the share price has softened...